can be explained by the release of the same substances
that are released in MA, in addition to the release of
enkephalins, β-endorphins and endorphins which activate
the m and δ-opioids and of dynorphins which
activate the κ-opioid receptors,19 31 which could
potentiate the effects of the treatment. However, in